Navigation Links
QIAGEN Gains Rights to Genomic Biomarkers for Lung, Brain and Other Cancers to Expand its Pipeline of Companion Diagnostics
Date:1/9/2012

f September 30, 2011, QIAGEN employed nearly 3,800 people in over 35 locations worldwide. Further information about QIAGEN can be found at http://www.qiagen.com/

Certain of the statements contained in this news release may be considered forward-looking statements within the meaning of Section 27A of the U.S. Securities Act of 1933, as amended, and Section 21E of the U.S. Securities Exchange Act of 1934, as amended. To the extent that any of the statements contained herein relating to QIAGEN's products, markets, strategy or operating results, and to expected growth of QIAGEN's business in Taiwan and Asia in particular, are forward-looking, such statements are based on current expectations that involve a number of uncertainties and risks. Such uncertainties and risks include, but are not limited to, risks associated with management of growth and international operations (including the effects of currency fluctuations and risks of dependency on logistics), variability of operating results, the commercial development of the applied testing markets, clinical research markets and proteomics markets, nucleic acid-based molecular diagnostics market, and genetic vaccination and gene therapy markets, competition, rapid or unexpected changes in technologies, fluctuations in demand for QIAGEN's products (including fluctuations due to the level and timing of customers' funding, budgets, and other factors), our ability to obtain regulatory approval of our infectious disease panels, difficulties in successfully adapting QIAGEN's products to integrated solutions and producing such products, the ability of QIAGEN to identify and develop new products and to differentiate its products from competitors' products, market acceptance of QIAGEN's new products and the integration of acquired technologies and businesses. For further information, refer to the discussions in reports that QIAGEN has filed with, or furnished to, the U.S. Securities and
'/>"/>

SOURCE QIAGEN N.V.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related biology technology :

1. SciQuest Announces Strategic Alliance with QIAGEN
2. QIAGEN Welcomes 3,000th Employee in 20th year of U.S. Operations
3. Webcast of QIAGEN N.V.s (Nasdaq: QGEN) Fourth Quarter and Year-End 2008 Financial Results Call Set for February 10
4. QIAGEN and Chittaranjan National Cancer Institute Partner to Establish First Large-Scale Cervical Cancer Screening Program in Kolkata
5. Plexus Awarded Development Contract With QIAGEN
6. Webcast of QIAGEN N.V.s (Nasdaq: QGEN) Second Quarter 2009 Financial Results Call Set for August 11
7. QIAGENs New Product Line, QIAsafe(R) DNA Blood, has Been Co-Developed With Biomatrica and is Based on Biomatricas SampleMatrix(R) Technology
8. QIAGEN Acquires Exclusive Licence for Key PI3K gene
9. QIAGEN Acquires Comprehensive Portfolio of Molecular Food Safety Tests
10. QIAGEN and Roche Settle Dispute Over Distribution Agreement for TheraScreen Companion Diagnostics
11. QIAGEN and Abbott Enter Into Agreement on Molecular Tests for HIV, HCV and HPV
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/30/2014)... PA (PRWEB) September 30, 2014 ... ( IACRN), a non-profit organization based in ... Research Excellence and Safety (ACRES), a Massachusetts ... a strategic alliance agreement, setting the stage for ... to enhance clinical research quality and safety through ...
(Date:9/29/2014)... , Sept. 29, 2014  Ten of ... fields of cartilage repair, regeneration, allograft reconstruction and ... around the world gathered to discuss the future ... Institute of Regenerative Medicine symposium, Cartilage Regeneration: ... Topics included Orthopedic Biosurgery, Minced Juvenile Allograft, and ...
(Date:9/29/2014)... lithium batteries are efficient but involve a range ... alfalfa (lucerne seed) and pine resin and a ... up with a highly interesting alternative. Their study ... ChemSusChem . , ,We think our discovery ... solutions for the batteries of the future, says ...
(Date:9/29/2014)... Diego, CA (PRWEB) September 29, 2014 ... Chen at Yale University the 2014 iCELLigence Research ... resistance studies. ACEA’s iCELLigence instrument is an impedance ... a Ph.D. candidate in Department of Biomedical Engineering ... Research Fellowship. Chen’s research projects in Professor ...
Breaking Biology Technology:IACRN and ACRES to Support Clinical Research Nurses 2IACRN and ACRES to Support Clinical Research Nurses 3World Renowned Experts Discuss Future Of Cartilage Regeneration 2World Renowned Experts Discuss Future Of Cartilage Regeneration 3Smart, eco-friendly new battery to solve problems 2ACEA Biosciences, Inc. Awards Yale University Researcher the iCELLigence Research Grant 2
... Medical,Innovations, Inc. (Amex: IMA ), a ... management services, announced that it received today ... directed at,Inverness, Binax subsidiary, awards Binax,s distributor ... interest and arbitration,related expenses. While Inverness is ...
... 25 Caraco Pharmaceutical,Laboratories, Ltd. (Amex: CPD ) ... ended June 30, 2008, of $108.3 million, as compared ... This represents an,increase of 206% over the first quarter ... the first quarter of Fiscal 2009 as compared to ...
... Inc. (Nasdaq:,INSM), a developer of follow-on biologics and ... call on Friday, August 8th at 8:30,AM ET, ... 2008. Insmed intends,to issue its quarterly financial results ... To participate in the live conference call, ...
Cached Biology Technology:Arbitration Panel Issues Ruling in Distribution Dispute 2Caraco Pharmaceutical Laboratories, Ltd. Reports Results for the First Quarter of Fiscal Year 2009 2Caraco Pharmaceutical Laboratories, Ltd. Reports Results for the First Quarter of Fiscal Year 2009 3Caraco Pharmaceutical Laboratories, Ltd. Reports Results for the First Quarter of Fiscal Year 2009 4Caraco Pharmaceutical Laboratories, Ltd. Reports Results for the First Quarter of Fiscal Year 2009 5Caraco Pharmaceutical Laboratories, Ltd. Reports Results for the First Quarter of Fiscal Year 2009 6Caraco Pharmaceutical Laboratories, Ltd. Reports Results for the First Quarter of Fiscal Year 2009 7Insmed to Host Second Quarter 2008 Conference Call 2
(Date:9/30/2014)... can live in almost any aquatic environment on Earth, ... many species are pushed to the limit. The amount ... prove critical for how different species cope in the ... University of Gothenburg, published in the scientific journal ... change continues apace thanks to increasing levels of greenhouse ...
(Date:9/30/2014)... you want your doctor to know what goes wrong with ... good idea to know what "normal" actually is. That,s where ... of the FASEB Journal comes in. ... transcriptomea key set of molecules that can help scientists "see" ... time. What,s more, they found never-before-detected gene activity and that ...
(Date:9/30/2014)... People who suffer from asthma may think there,s not ... besides properly taking medications and avoiding allergic triggers. ... Annals of Allergy, Asthma and Immunology , the scientific ... Immunology (ACAAI), asthma sufferers can learn lessons about managing ... in the Annals article improved her asthma once she ...
Breaking Biology News(10 mins):Shape up quickly -- applies to fish, too! 2Scientists identify which genes are active in muscles of men and women 2Asthma symptoms kicking up? Check your exposure to air pollution 2
... (March 26, 2009) The Howard Hughes Medical Institute ... Career Scientist appointment, a six-year funded position that allows ... am thrilled to receive the HHMI Early Career Scientist ... of supporting innovative and creative science, and I am ...
... team from the National Institute of Standards and Technology ... how to detect and monitor the tiny amount of ... atomic force microscope probe, and in so doing has ... instruments measurements under ambient conditions. Their recently reported work* ...
... researchers from the U.S., Europe, Taiwan and Japan and led ... agent that is about 200 times more active in killing ... The study appears this week in the ... agent belongs to a class of drugs called bisphosphonates. These ...
Cached Biology News:Whitehead member Peter Reddien named HHMI Early Career Scientist 2Making a point: Picoscale stability in a room-temperature AFM 2New drug agent knocks out multiple enzymes in cancer pathway 2
... samples may be carried out using this ... operator attention. System control and data processing ... 4900. The elegant, powerful and very easy ... Windows 98 and 2000., The supplied automatic sample ...
... in Minimum Essential Medium (Eagle) with 2 mM ... growth. In order to keep the antigens ... acetone-methanol. The cells are arrayed on a ... wells surface specifically treated to enhance cellular attachment ...
Mouse polyclonal antibody to REXO4 - XPMC2 prevents mitotic catastrophe 2 homolog (Xenopus laevis)...
... CellBIND surface is produced by a patented ... surface giving more consistent, even cell attachment, ... cell attachment and growth uunder difficult conditions, ... CellBIND may provide a more ecominic alternative ...
Biology Products: